J. Strosberg

Improved Outcome With Cytoreduction Versus Embolization for Symptomatic Hepatic Metastases of Carcinoid and Neuroendocrine Tumors

Dana Osborne, Emmanuel E. Zervos, J. Strosberg et al. · Annals of Surgical Oncology · 2006 · 219 citations

Surgical Oncology, Hepatology, Medicine +10

6LBA 177-Lu-Dotatate significantly improves progression-free survival in patients with midgut neuroendocrine tumours: Results of the phase III NETTER-1 trial

J. Strosberg, Edward M. Wolin, Beth Chasen et al. · European Journal of Cancer · 2015 · 56 citations

Progression-free Survival, Medicine, Pathology +6

A multi-institutional, phase II open-label study of ganitumab (AMG 479) in advanced carcinoid and pancreatic neuroendocrine tumors

J. Strosberg, Jennifer A. Chan, David P. Ryan et al. · Endocrine Related Cancer · 2013 · 37 citations · Full text

LBA53 Alliance A021602: Phase III, double-blinded study of cabozantinib versus placebo for advanced neuroendocrine tumors (NET) after progression on prior therapy (CABINET)

Jennifer A. Chan, Susan M. Geyer, F-S. Ou et al. · Annals of Oncology · 2023 · 27 citations · Full text

Lba53 Alliance A021602, Medicine, Phase Iii +9

5LBA Everolimus in advanced nonfunctional neuroendocrine tumors (NET) of lung or gastrointestinal (GI) origin: Efficacy and safety results from the placebo-controlled, double-blind, multicenter, Phase 3 RADIANT-4 study

James C. Yao, Nicola Fazio, Simron Singh et al. · European Journal of Cancer · 2015 · 10 citations

Gastrointestinal Oncology, Malignant Disease, Medicine +10